Delivery of molecular and cellular medicine to solid tumors

被引:86
|
作者
Jain, Rakesh K. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA
基金
美国国家科学基金会;
关键词
Tumor microcirculation; Angiogenesis; Blood flow; Vascular permeability; Diffusion and convection; Receptor-ligand binding; Interstitial pressure; Lymphatics; Cell adhesion and deformation; Cancer detection and treatment; INTERSTITIAL FLUID PRESSURE; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; NATURAL-KILLER-CELLS; POSITRON-EMISSION-TOMOGRAPHY; HUMAN ADENOCARCINOMA LS174T; INDUCED LEUKOCYTE ADHESION; NECROSIS-FACTOR-ALPHA; PERFUSED EX-VIVO; BLOOD-FLOW;
D O I
10.1016/j.addr.2012.09.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To reach cancer cells in a tumor, a blood-borne therapeutic molecule or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium, and finally migrate through the interstitium. Unfortunately, tumors often develop in ways that hinder each of these steps. Our research goals are to analyze each of these steps experimentally and theoretically, and then integrate the resulting information in a unified theoretical framework. This paradigm of analysis and synthesis has allowed us to obtain a better understanding of physiological barriers in solid tumors, and to develop novel strategies to exploit and/or to overcome these barriers for improved cancer detection and treatment. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:353 / 365
页数:13
相关论文
共 50 条